Eikan Mishima
Impact in
- Nephrology top 1%
- Dialysis and Renal Disease Management
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 13
- Gut microbiota and health 5
-
- Ferroptosis and cancer prognosis 12
- Renal and Vascular Pathologies 10
- Co-authors
- Takaaki Abe (40 shared papers)Marcus Conrad (11 shared papers)Sadayoshi Ito (29 shared papers)Takehiro Suzuki (25 shared papers)Yasutoshi Akiyama (13 shared papers)Kôichi Kikuchi (15 shared papers)Chitose Suzuki (11 shared papers)Bettina Proneth (4 shared papers)
- Journals
- Hypertension Research (6 papers)Toxins (4 papers)Journal of the American Society of Nephrology (4 papers)Journal of Clinical Hypertension (3 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Eikan Mishima
60 papers receiving 2.2k citations
Eikan Mishima's Hit Papers
Peers
Comparison fields: 5 of 115
- Nephrology 430
- Cancer Research 500
- Pulmonary and Respiratory Medicine 636
- Molecular Biology 1.2k
- Gastroenterology 83
Countries citing papers authored by Eikan Mishima
This map shows the geographic impact of Eikan Mishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eikan Mishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eikan Mishima more than expected).
Fields of papers citing papers by Eikan Mishima
This network shows the impact of papers produced by Eikan Mishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eikan Mishima. The network helps show where Eikan Mishima may publish in the future.
Co-authors
The 25 scholars most cited alongside Eikan Mishima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase separation of FSP1 promotes ferroptosis Hit paper breakdown → | 2023 | 228 |
| 2 | 2017 | 184 | |
| 3 | 2014 | 152 | |
| 4 | 2021 | 144 | |
| 5 | 2019 | 136 | |
| 6 | 2010 | 121 | |
| 7 | 2017 | 87 | |
| 8 | 2015 | 72 | |
| 9 | 2022 | 70 | |
| 10 | 2020 | 65 | |
| 11 | 2017 | 64 | |
| 12 | 2020 | 64 | |
| 13 | 2018 | 59 | |
| 14 | 2022 | 56 | |
| 15 | 2013 | 49 | |
| 16 | 2023 | 46 | |
| 17 | 2023 | 42 | |
| 18 | 2014 | 36 | |
| 19 | 2021 | 35 | |
| 20 | 2019 | 30 |
About Eikan Mishima
Eikan Mishima is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Nephrology, Cancer Research and Surgery, having authored 63 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Ferroptosis and cancer prognosis (12 papers), Renal and Vascular Pathologies (10 papers), Cancer, Lipids, and Metabolism (9 papers), Dialysis and Renal Disease Management (9 papers), Diet and metabolism studies (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Gut microbiota and health (5 papers). The work is most often cited by research in Nephrology (430 citations), Cancer Research (500 citations), Pulmonary and Respiratory Medicine (636 citations), Molecular Biology (1.2k citations) and Gastroenterology (83 citations). Eikan Mishima has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Takaaki Abe, Marcus Conrad, Sadayoshi Ito, Takehiro Suzuki, Yasutoshi Akiyama, Kôichi Kikuchi, Chitose Suzuki, Bettina Proneth, Tomoyoshi Soga and Yoshihisa Tomioka. Their work appears in journals such as Hypertension Research, Toxins, Journal of the American Society of Nephrology, Journal of Clinical Hypertension and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.